Works matching AU Sampol, Antonia
Results: 41
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S134, doi. 10.1016/S2152-2650(21)02305-3
- By:
- Publication type:
- Article
P-021: Experience with autologous stem-cell transplant (auto-SCT) in patients with systemic light-chain amyloidosis (LA) at our center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S51, doi. 10.1016/S2152-2650(21)02155-8
- By:
- Publication type:
- Article
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e289, doi. 10.1016/j.clml.2019.09.476
- By:
- Publication type:
- Article
Prescription Patterns and Outcomes of First-Line Therapy for Non-Transplant Eligible Multiple Myeloma Real-Life Patients According to Age: A Retrospective Analysis of the 2012-2016 Period.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e237, doi. 10.1016/j.clml.2019.09.395
- By:
- Publication type:
- Article
Prognostic Significance of Red Blood Cell Distribution Width (RDW) and Diverse Hemogram Ratios in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e178, doi. 10.1016/j.clml.2019.09.298
- By:
- Publication type:
- Article
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2217, doi. 10.1007/s00277-018-3438-y
- By:
- Publication type:
- Article
Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1364, doi. 10.3390/jcm11051364
- By:
- Publication type:
- Article
Total Lesion Glycolysis Improves Tumor Burden Evaluation and Risk Assessment at Diagnosis in Hodgkin Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4396, doi. 10.3390/jcm10194396
- By:
- Publication type:
- Article
Analysis of Personality Traits in Patients with Hodgkin Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1631, doi. 10.3390/jcm10081631
- By:
- Publication type:
- Article
Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review.
- Published in:
- Genes, 2022, v. 13, n. 10, p. N.PAG, doi. 10.3390/genes13101686
- By:
- Publication type:
- Article
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 6599, doi. 10.2147/OTT.S175016
- By:
- Publication type:
- Article
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 2093, doi. 10.2147/OTT.S70264
- By:
- Publication type:
- Article
Letter to the Editor Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Phase II trial of ofatumumab plus ESHAP (O- ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 859, doi. 10.1111/bjh.14133
- By:
- Publication type:
- Article
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen ( RIC) and post-allogeneic transplantation for high-risk myeloma patients.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 474, doi. 10.1111/bjh.12410
- By:
- Publication type:
- Article
Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS in vitro and correlates with inflammatory parameters and clinical severity.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1353106
- By:
- Publication type:
- Article
Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120316
- By:
- Publication type:
- Article
Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 695, doi. 10.2147/CEOR.S212257
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
The implication of 'unknown significance' variants in next‐generation sequencing in diagnosis and donor selection for allogenic haematopoietic stem cell transplantation. Report of a case of myelodysplastic syndrome with a polymorphism in the tyrosine kinase 2 (TYK2) gene
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. e182, doi. 10.1111/bjh.16590
- By:
- Publication type:
- Article
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 6, p. 631, doi. 10.1002/ajh.23167
- By:
- Publication type:
- Article
Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
- By:
- Publication type:
- Article
Busulfan‐based myeloablative conditioning regimens for haploidentical transplantation in high‐risk acute leukemias and myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 332, doi. 10.1111/ejh.13103
- By:
- Publication type:
- Article
Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179595
- By:
- Publication type:
- Article
Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 11, p. 1847, doi. 10.1080/10428194.2023.2240922
- By:
- Publication type:
- Article
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2383, doi. 10.1080/10428194.2017.1422858
- By:
- Publication type:
- Article
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 3, p. 656, doi. 10.3109/10428194.2014.930849
- By:
- Publication type:
- Article
Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma.
- Published in:
- Leukemia & Lymphoma, 2006, v. 47, n. 1, p. 111, doi. 10.1080/10428190500254752
- By:
- Publication type:
- Article
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2964, doi. 10.3390/cancers15112964
- By:
- Publication type:
- Article
Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3262, doi. 10.3390/cancers12113262
- By:
- Publication type:
- Article
Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267485
- By:
- Publication type:
- Article
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1066393
- By:
- Publication type:
- Article
MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201793
- By:
- Publication type:
- Article
Rhabdomyosarcoma debut masquerading as acute lymphoblastic leukemia: A case report and review of the literature.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 8, p. 1545, doi. 10.1002/ccr3.2284
- By:
- Publication type:
- Article